Physician profile
Timothy J Grass
NPI 1982719134
$452.68
in general payments reported to CMS, 2019-2025
13 companies · $39.66 in 2025
The $39.66 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2024: $51.06 · 2025: $39.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $67.38 | 2019 | |
| Exact Sciences Corporation | $63.13 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.62 | 2019 | |
| Allergan, INC. | $31.65 | 2019 | |
| Dynavax Technologies Corporation | $27.59 | 2024 | Heplisav-B |
| Merck Sharp & Dohme LLC | $27.19 | 2019 | |
| Glaxosmithkline, LLC. | $25.68 | 2019 | |
| Abbvie INC. | $23.87 | 2019 | |
| Ironshore Pharmaceuticals INC. | $21.84 | 2019 | |
| Amgen INC. | $16.46 | 2019 | |
| Shire North American Group INC | $14.02 | 2019 | |
| Pfizer INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Grass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.